Strides Pharma Science has informed that it enclosed a press release today titled ‘Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer’s COVID-19 Oral Treatment across 95 markets.’
The above information is a part of company’s filings submitted to BSE.